SEER
Seer IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$95.35M
P/E Ratio
—
EPS
$-1.28
Beta
1.60
52W High
$2.41
52W Low
$1.65
50-Day MA
$1.83
200-Day MA
$2.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Seer Inc
Seer, Inc., a life sciences company, is dedicated to developing and marketing products for researchers to unlock biological information. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $16.58M |
| Gross Profit (TTM) | $8.46M |
| EBITDA | $-71.89M |
| Operating Margin | -413.80% |
| Return on Equity | -25.10% |
| Return on Assets | -14.70% |
| Revenue/Share (TTM) | $0.29 |
| Book Value | $4.61 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 5.75 |
| EV/Revenue | 0.0835 |
| EV/EBITDA | 1.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 5.00% |
| Shares Outstanding | $56.42M |
| Float | $37.54M |
| % Insiders | 9.78% |
| % Institutions | 55.34% |
Analyst Ratings
Consensus ($3.00 target)
1
BuyData last updated: 4/9/2026